Literature DB >> 21103450

An Effective Way to Solve Equivocal Mammography Findings: The Rolled Views.

Emel Alimoglu1, Kagan Ceken, Adnan Kabaalioglu, Enrico Cassano, Timur Sindel.   

Abstract

SUMMARY:
BACKGROUND: The aim of this study was to investigate the efficacy of the rolled views taken in craniocaudal (CC) and mediolateral oblique (MLO) projections in solving equivocal mammography findings. PATIENTS AND METHODS: The rolled views were taken by changing the positioning of the breast but not the obliquity of the X-ray beams. The breast was rolled medially or laterally in the rolled CC view, and inferiorly or superiorly in the rolled MLO view to separate overlapping structures from each other.
RESULTS: We evaluated equivocal findings in 87 asymptomatic women undergoing either CC (n = 48, 55%) or MLO (n = 39, 45%) rolled views between 2001 and 2008. The rolled views were helpful in solving equivocal mammographic findings and making proper decisions on management in 85 of the 87 (97.7%) women. This technique was used for breast asymmetries in 55 of the 87 (63.2%) women, and was sufficient to directly show summation artifacts in 59 of 79 (74.6%) women. The rolled views revealed 4 intramammary lymph nodes, 2 circumscribed masses out of 6 obscured masses, 7 summation artifacts, and 2 circumscribed masses out of 9 questionable masses.
CONCLUSIONS: The rolled view is an effective method of differentiating summation artifacts from real lesions on mammography in both the CC and the MLO view.

Entities:  

Year:  2010        PMID: 21103450      PMCID: PMC2978743          DOI: 10.1159/000313904

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  13 in total

Review 1.  False-negative mammograms. Medical, legal, and risk management implications.

Authors:  R J Brenner
Journal:  Radiol Clin North Am       Date:  2000-07       Impact factor: 2.303

2.  Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation.

Authors:  Işil Günhan-Bilgen; Ayşenur Memiş; Esin Emin Ustün; Necmettin Ozdemir; Yildiz Erhan
Journal:  Eur J Radiol       Date:  2002-12       Impact factor: 3.528

3.  Efficacy of step-oblique mammography for confirmation and localization of densities seen on only one standard mammographic view.

Authors:  K L Pearson; E A Sickles; S D Frankel; J W Leung
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

4.  The spectrum of breast asymmetries: imaging features, work-up, management.

Authors:  Edward A Sickles
Journal:  Radiol Clin North Am       Date:  2007-09       Impact factor: 2.303

5.  Equivocal mammographic findings: evaluation with spot compression.

Authors:  J E Berkowitz; O M Gatewood; B W Gayler
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

6.  Practical solutions to common mammographic problems: tailoring the examination.

Authors:  E A Sickles
Journal:  AJR Am J Roentgenol       Date:  1988-07       Impact factor: 3.959

Review 7.  Focal asymmetric densities seen at mammography: US and pathologic correlation.

Authors:  Polya Samardar; Ellen Shaw de Paredes; Margaret M Grimes; John D Wilson
Journal:  Radiographics       Date:  2002 Jan-Feb       Impact factor: 5.333

8.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.

Authors:  Wendie A Berg; Lorena Gutierrez; Moriel S NessAiver; W Bradford Carter; Mythreyi Bhargavan; Rebecca S Lewis; Olga B Ioffe
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

9.  Mammographic features of 300 consecutive nonpalpable breast cancers.

Authors:  E A Sickles
Journal:  AJR Am J Roentgenol       Date:  1986-04       Impact factor: 3.959

10.  Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging.

Authors:  Rachel F Brem; Marina Ioffe; Jocelyn A Rapelyea; Kristen G Yost; Jean M Weigert; Margaret L Bertrand; Lillian H Stern
Journal:  AJR Am J Roentgenol       Date:  2009-02       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.